Hostname: page-component-848d4c4894-x5gtn Total loading time: 0 Render date: 2024-05-03T05:00:30.579Z Has data issue: false hasContentIssue false
  • English
  • Français

Bullous Pemphigoid in an Infant: A Case Report

Published online by Cambridge University Press:  22 June 2018

Oscar Thabouillot ,
Julien Le Coz  and
Nicolas-Charles Roche
Oscar Thabouillot*
Affiliation:
Pediatric Emergency Department, Robert Debré Teaching Hospital, Paris, France Bégin Military Teaching Hospital, Saint-Mandé, France
Julien Le Coz
Affiliation:
Pediatric Emergency Department, Robert Debré Teaching Hospital, Paris, France
Nicolas-Charles Roche
Affiliation:
Bégin Military Teaching Hospital, Saint-Mandé, France
*
Correspondence: Oscar Thabouillot Pediatric Emergency Department Robert Debré Teaching Hospital Paris, France E-mail: thabouillot@hotmail.com
Get access Rights & Permissions [Opens in a new window]

Abstract

A seven-month-old girl was referred to the emergency department (ED) after a general practitioner suspected Steven-Johnson syndrome. Actually, the diagnosis of bullous pemphigoid (BP) was made based on biopsies; BP is a rare, autoimmune skin disease involving the presence of blisters known as bullae. The child was efficiently treated with topical steroids. This case shows the importance of the ED physician’s prior knowledge of BP so that a differential diagnosis with other autoimmune diseases (dermatosis, pemphigus) can be made.

Thabouillot O, Le Coz J, Roche NC. Bullous pemphigoid in an infant: a case report. Prehosp Disaster Med. 2018;33(4):448–450.

Keywords

autoimmune diseasesbullous pemphigoidemergency departmentinfant
Type
Case Report
Information
Prehospital and Disaster Medicine , Volume 33 , Issue 4 , August 2018 , pp. 448 - 450
Copyright
© World Association for Disaster and Emergency Medicine 2018 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Conflicts of interest: none

References

1. Kong, YL, Lim, YL, Chandran, NS. Retrospective study on autoimmune blistering disease in paediatric patients. Pediatr Dermatol. 2015;32(6):845-852.Google Scholar
2. Waisbourd-Zinman, O, Ben-Amitai, D, Cohen, AD, et al. Bullous pemphigoid in infancy: clinical and epidemiologic characteristics. J Am Acad Dermatol. 2008;58(1):41-48.Google Scholar
3. Akin, MA, Gunes, T, Akýn, L, et al. A newborn with bullous pemphigoid associated with linear IgA bullous dermatosis. Acta Dermatovenerol Alp Pannonica Adriat. 2009;18(2):66-70.Google Scholar
4. Joly, P, et al. Haute Autorité de Santé. April 2016. Protocole national de diagnostic et de soins de la pemphigoïde bulleuse. http://www.has-sante.fr/portail/upload/docs/application/pdf/2016-06/pnds_-_pemphigoide_bulleuse_pb.pdf [in French]. Accessed December 1, 2017.Google Scholar
5. Fine, JD. Clinical and immunological factors associated with bullous pemphigoid relapse. JAMA Dermatol. 2014;150(1):34.Google Scholar
6. Ister, M, Pouessel, G, Ythier, H, et al. Post-vaccinal, corticosteroid-resistant bullous pemphigoid in infancy: treatment with intravenous immunoglobulin. Pediatr Dermatol. 2014;31(4):e94-e95.Google Scholar
7. Seminario-Vidal, L, Sami, N, Miller, J, et al. Mycophenolate mofetil therapy for pediatric bullous pemphigoid. Dermatol Online J. 2015;21(8).Google Scholar
Supplementary material: File

Thabouillot et al. supplementary material

Thabouillot et al. supplementary material 1

Download Thabouillot et al. supplementary material(File)
File 718.5 KB
Supplementary material: File

Thabouillot et al. supplementary material

Thabouillot et al. supplementary material 2

Download Thabouillot et al. supplementary material(File)
File 426.1 KB